TheraRadar

Syntara

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 11/8/2023

15
Total Trials
3
Phase 3
9
Phase 2
1
Recruiting
135
Score

Pipeline by Phase

Phase 3
3
Phase 2
9
Phase 1
6

Therapeutic Focus

Cystic Fibrosis Bronchiectasis Asthma Myelofibrosis REM Sleep Behavior Disorder

Clinical Trials (15)

NCT02134353 Phase 3 COMPLETED

A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects

Started: 9/1/2014

NCT00630812 Phase 3 COMPLETED

Long Term Administration of Inhaled Mannitol in Cystic Fibrosis

Started: 9/1/2008

NCT00669331 Phase 3 COMPLETED

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

Started: 11/1/2009

NCT05904717 Phase 2 ACTIVE NOT RECRUITING

Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

Started: 11/8/2023

NCT01883531 Phase 2 COMPLETED

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Started: 6/1/2013

NCT00550797 Phase 2 COMPLETED

Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma

Started: 1/1/2008

NCT01158898 Phase 2 COMPLETED

Efficacy of TPI ASM8 During a 14-Day Allergen Challenge

Started: 11/1/2010

NCT00822861 Phase 2 COMPLETED

Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma

Started: 4/1/2009

NCT01380236 Phase 2 WITHDRAWN

A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

Started: 11/1/2011

NCT04676529 Phase 1 COMPLETED

Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

Started: 2/18/2021

NCT04183517 Phase 1 COMPLETED

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

Started: 12/20/2019

NCT00914433 Phase 1 WITHDRAWN

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

Started: 4/1/2009

NCT01076491 Phase 1 COMPLETED

High Dose Inhaled Mannitol Study

Started: 1/1/2009

NCT00792714 Phase 1 COMPLETED

Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients

Started: 12/1/2008

NCT00730977 Phase 1 COMPLETED

A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device

Started: 8/1/2008

Drug Candidates

PXS-5505 PXS-4728 (A) Matching Placebo (B) Inhaled mannitol Placebo Comparator: Arm B - Control inhaled mannitol Placebo comparator PXS-5382A Matched control Inhaled Mannitol
Activity Status: Stale
Last Trial Started: 11/8/2023
Last Trial Ended: 7/9/2025
Trials (12 months): 0
Completed Trials: 12
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.